1. VRK1 promotes cisplatin resistance by up-regulating c-MYC via c-Jun activation and serves as a therapeutic target in esophageal squamous cell carcinoma
   Zhen-Chuan Liu et al, 2017, Oncotarget CrossRef
2. T‑cell immunoglobulin and mucin domain‑containing protein‑3 and galectin‑9 protein expression: Potential prognostic significance in esophageal squamous cell carcinoma for Chinese patients
   Nan Hou et al, 2017, Oncology Letters CrossRef
3. Impact of pretreatment plasma D-dimer levels and its perioperative change on prognosis in operable esophageal squamous cell carcinoma
   Jianbo Li et al, 2017, Oncotarget CrossRef
4. DNA Damage Response Mechanisms in Head and Neck Cancer: Significant Implications for Therapy and Survival
   Chara Papalouka et al, 2023, International Journal of Molecular Sciences CrossRef
5. RasGRP3, a Ras guanyl releasing protein 3 that contributes to malignant proliferation and aggressiveness in human esophageal squamous cell carcinoma
   Ziteng Zhang et al, 2018, Clinical and Experimental Pharmacology and Physiology CrossRef